Home > Publications > Angiogenesis in cancer, vascular, rheumatoid and other disease
Publications

Nature Medicine 1995 Jan;1(1):27-31

Angiogenesis in cancer, vascular, rheumatoid and other disease

J Folkman

Abstract

Recent discoveries of endogenous negative regulators of angiogenesis, thrombospondin, angiostatin and glioma-derived angiogenesis inhibitory factor, all associated with neovascularized tumours, suggest a new paradigm of tumorigenesis. It is now helpful to think of the switch to the angiogenic phenotype as a net balance of positive and negative regulators of blood vessel growth. The extent to which the negative regulators are decreased during this switch may dictate whether a primary tumour grows rapidly or slowly and whether metastases grow at all.